Spyre Therapeutics Inc. Cash Flow Reinvestment Rate
Latest as of June 2021:
0.01x
Spyre Therapeutics Inc. cash flow reinvestment rate. Spyre Therapeutics Inc. (SYRE) has a Cash Flow Reinvestment Rate of 0.01x as of June 2021, reinvesting $30.00K (capex $30.00K ) from operating cash flow of $2.08 Million. Explore Spyre Therapeutics Inc. (SYRE) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.01x
(Capex + Investments) / Operating CF
Total Reinvested
$30.00K
Capex + Investments
Operating Cash Flow
$2.08 Million
USD
Capital Expenditures
$30.00K
USD
Spyre Therapeutics Inc. Cash Flow Reinvestment Rate by Year (None–None)
Spyre Therapeutics Inc. cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Spyre Therapeutics Inc.. For the full cash flow conversion analysis, see SYRE cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow